Tanja Kroell

High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML)

Michaela Graf, Susanne Reif, Karin Hecht et al. · Annals of Hematology · 2004 · 72 citations

Hematological Malignancy, Costimulatory Molecules, Mixed-phenotype Acute Leukemia +10

Dendritic Cells (DCs) Can Be Successfully Generated From Leukemic Blasts in Individual Patients With AML or MDS

Andreas Kremser, Julia Dreyig, Christine Grabrucker et al. · Journal of Immunotherapy · 2010 · 65 citations

Leukemic Blasts, Hematological Malignancy, Individual Patients +15

The Quality and Quantity of Leukemia-derived Dendritic Cells From Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome Are a Predictive Factor for the Lytic Potential of Dendritic Cells-primed Leukemia-Specific T Cells

Christine Grabrucker, Anja Liepert, Julia Dreyig et al. · Journal of Immunotherapy · 2010 · 42 citations

Cell Therapy, Immunology, Immunoediting +17

Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes

Stefanie Kufner, Richard Fleischer, Tanja Kroell et al. · Cancer Immunology Immunotherapy · 2005 · 37 citations · Full text

Hematological Malignancy, Active Leukemia-derived Dc, Mixed-phenotype Acute Leukemia +11

Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential

Anja Liepert, Christine Grabrucker, Andreas Kremser et al. · Cellular Immunology · 2010 · 30 citations

Hematological Malignancy, Cell Therapy, Medicine +10